IceCure Medical Schedules Shareholder Meeting for May 15
Ticker: ICCM · Form: 6-K · Filed: Apr 10, 2025 · CIK: 1584371
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
Related Tickers: ICCM
TL;DR
ICCM holding shareholder meeting May 15, record date April 16 - vote on company's future.
AI Summary
IceCure Medical Ltd. has filed a Form 6-K on April 10, 2025, announcing a Special General Meeting of Shareholders scheduled for May 15, 2025. Shareholders of record as of April 16, 2025, are eligible to vote at this meeting, which will include a Proxy Statement and Proxy Card.
Why It Matters
This filing signals upcoming corporate decisions or votes by shareholders that could impact the company's strategic direction or governance.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing a shareholder meeting, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- May 15, 2025 (date) — Special General Meeting date
- April 16, 2025 (date) — Record date for shareholders
FAQ
What is the purpose of the Special General Meeting of Shareholders?
The purpose is to hold a meeting for shareholders to vote on matters presented in the Notice of Meeting, Proxy Statement, and Proxy Card.
Who is eligible to vote at the meeting?
Shareholders of record who hold Ordinary Shares at the close of business on Wednesday, April 16, 2025, are entitled to vote.
When is the Special General Meeting scheduled to take place?
The meeting is scheduled for Thursday, May 15, 2025.
What form is being filed with the SEC?
A Form 6-K, Report of Foreign Private Issuer.
What is the company's principal executive office address?
7 Ha'Eshel St., PO Box 3163, Caesarea, 3079504, Israel.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding IceCure Medical Ltd. (ICCM).